肝脏 ›› 2020, Vol. 25 ›› Issue (7): 686-688.

• 肝癌 • 上一篇    下一篇

肝脏神经内分泌肿瘤与肝细胞癌超声学特征的差异比较

周艳珂, 王敬敏, 田婧, 李潜   

  1. 450008 郑州大学附属肿瘤医院超声科(周艳珂,王敬敏,李潜);河南中医药大学第一附属医院超声科(田婧)
  • 收稿日期:2019-12-31 发布日期:2020-08-06
  • 基金资助:
    河南省中医药科学研究专项课题(2017ZY2055)

Comparison of ultrasonographic characteristics between haptic neuroendocrine neoplasm and hepatocellular carcinoma

ZHOU Yan-ke, WANG Jing-min, TIAN Jing, LI Qian   

  1. Department of Ultrasound, Affiliated Tumor Hospital of Zhengzhou University, Henan 450008,China
  • Received:2019-12-31 Published:2020-08-06

摘要: 目的: 比较肝脏神经内分泌肿瘤(HNEN)、肝细胞癌超声学特征的差异。方法: 选取2017年2月至2019年8月期间就治于郑州大学附属肿瘤医院的肝脏HNEN患者22例,同时随机选取同期肝细胞癌患者30例,比较两组患者的超声特征,统计学处理采用t检验和卡方检验。结果: HNEN、肝细胞癌常规超声特征中,病灶平均数目、边界、病灶内部回声、回声均匀性及后方回声衰减等具有显著差异(P<0.05),而病灶位置、大小及血流信号等无明显统计学差异(P>0.05)。HNEN、肝细胞癌超声造影特征中,开始消退时间、增强持续时间及消退速度等具有显著差异(P<0.05),而开始增强时间、增强速度、增强形式及增强强度等无明显统计学差异(P>0.05)。结论: 基于超声及超声造影的检查能够有效反映HNEN和肝细胞癌的差异,有助于临床实践中对两种病灶的鉴别。

关键词: 肝脏神经内分泌肿瘤, 超声造影, SonoVue, 原发性肝癌, 转移性肝癌

Abstract: Objective To compare the ultrasonographic characteristics between hepatic neuroendocrine neoplasm (hNEN) and hepatocellular carcinoma. Methods Twenty-two patients with hNEN treated in our department from February 2017 to August 2019 were selected, including 14 males and 8 females, 1 case of primary hNEN and 21 cases of metastatic hNEN, with an average age of (50.6 ± 10.0) years. The primary sites of metastatic hNEN included pancreas (n = 8), stomach (n = 5), small intestine (n = 4), colorectal (n = 3) and lung (n = 1). During the same period, 30 patients with hepatocellular carcinoma were randomly selected, including 23 males and 7 females, 26 cases of primary hepatocellular carcinoma and 4 cases of metastatic hepatocellular carcinoma, with an average age of (52.2 ± 7.9) years. The measurement data were expressed as (±s), compared with t-test, and the count data were expressed as (%) and compared with chi-square test. Results Using conventional ultrasound, there were significant differences in the average number of lesions, boundary, internal echo, echotexture and posterior echo attenuation between hNEN and hepatocellular carcinoma (P<0.05). There was no significant difference in lesion location, size and blood flow signal (P > 0.05). Using contrast-enhanced ultrasound, there were significant differences in the initial enhancement washout time, enhancement duration and washout rate between hNEN and hepatocellular carcinoma (P<0.05). There was no significant difference in initial enhancement time, enhancement rate, enhancement pattern and enhancement degree (P > 0.05). Conclusion Both conventional ultrasound and contrast-enhanced ultrasonography can effectively show the difference between hNEN and hepatocellular carcinoma, which were helpful to the differentiation of the 2 kinds of lesions in clinical practice.

Key words: Hepatic neuroendocrine neoplasm, Contrast-enhanced ultrasound, SonoVue, Primary liver cancer, Metastatic liver cancer